Table 4 FET-TFCP2 rhabdomyosarcomas reported in the literature

From: A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation

Author

Case ID

Age (y)/gender

Location

Tumor size

Morphology

IHC

Molecular

Therapy

Survival

Dashti et al. [7], 1 case

72/M

Mandible

4 cm

Monomorphic spindled and epithelioid cells arranged in short fascicles. No stroma.

Des+ MYOD1+ S100 focal+ Keratin+ ALK+

FUS (exon 6)-TFCP2 (exon 2)

Radical mandibulectomy

2 Months after surgery disease free

Zhu et al. [10], 1 case

Case 5

74/F

Maxilla

4 cm

Monomorphic spindle cells with inflammatory background. Frequent mitotic figures and focal necrosis.

Des+ MYOD1+ S100− Keratin− ALK+

FUS (exon 6)-TFCP2 (exon 2)

NA

Regional metastasis to the neck

Agaram et al. [8], 4 cases

Case 3

27/F

Skull

NA

Epithelioid

Des+ MYOD1+ Keratin + ALK+

EWSR1-TFCP2

NA

NA

Case 4

33/F

Maxilla

Epithelioid

EWSR1-TFCP2

Surgical resection

ANED (108 months FO)

Case 5

20/M

Iliac bone

Pure spindle cell morphology

EWSR1-TFCP2

NA

NA

Case 6

37/F

Femoral bone

Pure spindle cell morphology

FUS-TFCP2

NA

NA

Tagami et al. [9], 1 case

70/F

Lumbar vertebra

NA

Spindled to round cells, scattered rhabdomyoblasts

Des focal + MYOD1 + S100 − Keratin + ALK +

FUS rearrangement

Surgery followed by chemotherapy and radiotherapy

Still alive after 6 month of diagnosis

Wong et al. [20], 1 case

23/M

Nasal cavity

8 cm

Monomorphic epithelioid, and rhabdoid and spindled cells. High mitotic count >30 per 10 HPF

Des focal + MYOD1+ MYF4 focal+ S100− Keratin− ALK+

FUS-TFCP2

No response to combination of chemotherapy and radiotherapy, currently treated with Crizotinib (ALK inhibitor)

AWD (2 months FO)

  1. ANED alive no evidence of disease, AWD alive with disease, FO follow-up, Des Desmin